Results 231 to 240 of about 60,681 (284)

The pharmacokinetic interaction between zidovudine and trimethoprim-sulfamethoxazole in HIV-1 infected children

, 1998
Shannon Robertson‐Dallas
openalex   +1 more source

Pyrimidine nucleoside: inspiration for novel antimicrobial agent. [PDF]

Front Pharmacol
Xu B, Li P, Liu J, Li M.
europepmc   +1 more source

Retraction: The iron group transition-metal (Fe, Ru, Os) coordination of Se-doped graphitic carbon (Se@g-C₃N₄) nanostructures for the smart therapeutic delivery of zidovudine (ZVD) as an antiretroviral drug: a theoretical calculation perspective. [PDF]

RSC Adv
Nelson FA, Louis H, Benjamin I, Timothy RA.   +3 more
europepmc   +1 more source

Kidney Dysfunction In Young People Living With HIV On Dolutegravir-Based Regimens In Kampala, Uganda

Nasuuna EM, Hoffman R, Kalyesubula R, Chikwari CD, Weiss HA.   +4 more
europepmc   +1 more source

Modulation of IRF7-driven transcription as a strategy to control HIV-1 latency. [PDF]

Front Immunol
Ezeonwumelu IJ, Garcia-Vidal E, Felip E, Cabrero-de Las Heras S, Clotet B, Badia R, Ballana E, Riveira-Muñoz E, Nevot M.   +8 more
europepmc   +1 more source

An Aqueous-Compatible On-Column Approach for the Conjugation of Nucleic Acids Using Amino Modifiers. [PDF]

Curr Protoc
Saraya JS, O'Flaherty DK.
europepmc   +1 more source

Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial

, 2001
Cab Boucher
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Zidovudine in synergistic combination with fosfomycin: an in vitro and in vivo evaluation against multidrug-resistant Enterobacterales.

International Journal of Antimicrobial Agents, 2021
BACKGROUND MDR Enterobacterales are a priority health issue with few options. Recently, fosfomycin has been reconsidered for MDR bacterial infections.
R. M. Antonello, Stefano Di Bella, J. Betts, R. L. La Ragione, Raffaela Bressan, Luigi Principe, S. Morabito, F. Gigliucci, R. Tozzoli, M. Busetti, A. Knezevich, L. Furlanis, F. Fontana, F. Luzzaro, R. Luzzati, C. Lagatolla   +15 more
semanticscholar   +1 more source

Zidovudine Intolerance

Clinical Infectious Diseases, 1990
Patients may be intolerant of zidovudine for several reasons, the most prominent being hematologic toxicity. In vitro studies demonstrate that zidovudine is toxic to the myeloid and erythroid precursors in the bone marrow; at concentrations of zidovudine near those associated with the optimal antiviral effect in vitro, the proliferative capability of ...
openaire   +2 more sources